Cancer survival fell and deaths rose during first two years of COVID-19ByBriana ContrerasFebruary 6th 2026
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvalsByAndrew Cox, Pharm.D., MBAFebruary 6th 2026
7 things you need to know about the PBM reforms signed into law this weekByDenise Myshko,Peter Wehrwein, Managing EditorFebruary 6th 2026